Mortality reduction with levosimendan in patients with heart failure: Current evidence is underpowered

Detalles Bibliográficos
Autores principales: Sanfilippo, Filippo, La Via, Luigi, Merola, Federica, Astuto, Marinella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2021
Materias:
Clinical Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428938/
https://www.ncbi.nlm.nih.gov/pubmed/34240399
http://dx.doi.org/10.5603/CJ.a2021.0078
_version_ 1783750468468473856
author Sanfilippo, Filippo
La Via, Luigi
Merola, Federica
Astuto, Marinella
author_facet Sanfilippo, Filippo
La Via, Luigi
Merola, Federica
Astuto, Marinella
author_sort Sanfilippo, Filippo
collection PubMed
description
format Online
Article
Text
id pubmed-8428938
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Via Medica
record_format MEDLINE/PubMed
spelling pubmed-84289382021-09-10 Mortality reduction with levosimendan in patients with heart failure: Current evidence is underpowered Sanfilippo, Filippo La Via, Luigi Merola, Federica Astuto, Marinella Cardiol J Clinical Cardiology Via Medica 2021-07-07 /pmc/articles/PMC8428938/ /pubmed/34240399 http://dx.doi.org/10.5603/CJ.a2021.0078 Text en Copyright © 2021 Via Medica https://creativecommons.org/licenses/by-nc-nd/4.0/This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
spellingShingle Clinical Cardiology
Sanfilippo, Filippo
La Via, Luigi
Merola, Federica
Astuto, Marinella
Mortality reduction with levosimendan in patients with heart failure: Current evidence is underpowered
title Mortality reduction with levosimendan in patients with heart failure: Current evidence is underpowered
title_full Mortality reduction with levosimendan in patients with heart failure: Current evidence is underpowered
title_fullStr Mortality reduction with levosimendan in patients with heart failure: Current evidence is underpowered
title_full_unstemmed Mortality reduction with levosimendan in patients with heart failure: Current evidence is underpowered
title_short Mortality reduction with levosimendan in patients with heart failure: Current evidence is underpowered
title_sort mortality reduction with levosimendan in patients with heart failure: current evidence is underpowered
topic Clinical Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428938/
https://www.ncbi.nlm.nih.gov/pubmed/34240399
http://dx.doi.org/10.5603/CJ.a2021.0078
work_keys_str_mv AT sanfilippofilippo mortalityreductionwithlevosimendaninpatientswithheartfailurecurrentevidenceisunderpowered
AT lavialuigi mortalityreductionwithlevosimendaninpatientswithheartfailurecurrentevidenceisunderpowered
AT merolafederica mortalityreductionwithlevosimendaninpatientswithheartfailurecurrentevidenceisunderpowered
AT astutomarinella mortalityreductionwithlevosimendaninpatientswithheartfailurecurrentevidenceisunderpowered

Ejemplares similares